Free Trial

20 Stocks Analysts Won't Stop Upgrading - 10 of 20

 
 

DoorDash (NASDAQ:DASH)

Number of Upgrades
25 (in the last 90 days)
Consensus Rating
Moderate Buy
Rating Score
2.7
Ratings Breakdown
24 Buy Ratings, 10 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$163.12 (2.8% Downside)

About DoorDash

DoorDash logoDoorDash, Inc, together with its subsidiaries, operates a commerce platform that connects merchants, consumers, and independent contractors in the United States and internationally. The company operates DoorDash Marketplace and Wolt Marketplace, which provide various services, such as customer acquisition, demand generation, order fulfillment, merchandising, payment processing, and customer support. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/1/2024The Goldman Sachs GroupBoost Price TargetNeutral ➝ Neutral$142.00 ➝ $161.00
11/1/2024SusquehannaBoost Price TargetPositive ➝ Positive$140.00 ➝ $180.00
11/1/2024BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$120.00 ➝ $163.00
10/31/2024JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$160.00 ➝ $190.00
10/31/2024KeyCorpBoost Price TargetOverweight ➝ Overweight$177.00 ➝ $180.00
10/31/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$165.00 ➝ $175.00
10/31/2024Truist FinancialBoost Price TargetBuy ➝ Buy$170.00 ➝ $180.00
10/31/2024Evercore ISIBoost Price TargetOutperform ➝ Outperform$155.00 ➝ $200.00
10/31/2024JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$137.00 ➝ $155.00
10/31/2024Piper SandlerBoost Price TargetNeutral ➝ Neutral$125.00 ➝ $160.00

Recent Recommendations for DoorDash:

  • DoorDash, Inc. (NASDAQ: DASH) had its price target raised by analysts at Susquehanna from $140.00 to $180.00. They now have a "positive" rating on the stock. (11/1/2024)
  • DoorDash, Inc. (NASDAQ: DASH) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $142.00 to $161.00. They now have a "neutral" rating on the stock. (11/1/2024)
  • DoorDash, Inc. (NASDAQ: DASH) had its price target raised by analysts at Barclays PLC from $120.00 to $163.00. They now have an "equal weight" rating on the stock. (11/1/2024)
  • DoorDash, Inc. (NASDAQ: DASH) had its price target raised by analysts at KeyCorp from $177.00 to $180.00. They now have an "overweight" rating on the stock. (10/31/2024)
  • DoorDash, Inc. (NASDAQ: DASH) had its price target raised by analysts at Royal Bank of Canada from $165.00 to $175.00. They now have an "outperform" rating on the stock. (10/31/2024)
  • DoorDash, Inc. (NASDAQ: DASH) had its price target raised by analysts at Evercore ISI from $155.00 to $200.00. They now have an "outperform" rating on the stock. (10/31/2024)
  • DoorDash, Inc. (NASDAQ: DASH) had its price target raised by analysts at BMO Capital Markets from $140.00 to $180.00. They now have an "outperform" rating on the stock. (10/31/2024)
  • DoorDash, Inc. (NASDAQ: DASH) had its price target raised by analysts at JPMorgan Chase & Co. from $137.00 to $155.00. They now have a "neutral" rating on the stock. (10/31/2024)
  • DoorDash, Inc. (NASDAQ: DASH) had its price target raised by analysts at Piper Sandler from $125.00 to $160.00. They now have a "neutral" rating on the stock. (10/31/2024)
  • DoorDash, Inc. (NASDAQ: DASH) had its price target raised by analysts at DA Davidson from $119.00 to $150.00. They now have a "neutral" rating on the stock. (10/31/2024)
 

NASDAQ traded stock with a BIG short position. (Ad)

Small cap NASDAQ firm is an innovative leader in non-opioid pain therapeutics. The company’s offerings could significantly aid in stopping the opioid crisis and create maximum shareholder growth!

See how this NASDAQ Bio-tech is offering viable solutions